Gabriela Rossi

Gabriela Rossi has extensive experience in regulatory affairs, spanning over 20 years. Gabriela currently holds the position of Vice President of Regulatory Affairs at iTeos Therapeutics, a role they have held since October 2020. Prior to this, they served as Vice President of Regulatory Affairs at Kura Oncology, Inc. from May 2019 to June 2020. Before joining Kura Oncology, Inc., Gabriela worked at EMD Serono, Inc. as a Senior Director of Global Regulatory Affairs in the Oncology division from November 2015 to April 2019. Gabriela also held the position of Director of Regulatory Affairs at TESARO from September 2012 to October 2015. Gabriela's earlier career includes roles at PAREXEL as a Senior Consultant from March 2011 to September 2012, Sanofi Pasteur as a Manager of Regulatory Affairs from October 2008 to October 2010, and Genzyme as an Associate Director of Regulatory Affairs from 1998 to 2008.

Gabriela Rossi completed their education with a degree in Pharmacy from the University of Buenos Aires in 1994. Gabriela also received a Certificate in Business Administration and Management from Harvard University in 1997. Additionally, Gabriela pursued Biochemistry at the University of Buenos Aires before completing their education. Gabriela also attended the Northwestern University - Kellogg School of Management for the RAPS Executive Development Program, although the specific duration is not provided. Furthermore, they attended the Modern School, although no further details are provided regarding this educational experience.